What is immuno-autonomics?
Click on the new educational animation from Inmedix and Random42, London.
Inmedix CEO & Co-founder, Andrew J. Holman, MD, interviewed at the 2017 Biotech & Money London meeting, November, 2017.
Thank you all for supporting
We raised another $16,000 this year!
We're already preparing for Monday, August 24, 2020.